Lin, L., Wen, J., Xu, T., & Si, Y. TM4SF4 is a diagnostic biomarker accelerating progression of papillary thyroid cancer via AKT pathway. Taylor & Francis Group.
Chicago Style (17th ed.) CitationLin, Lizhi, Jialiang Wen, Tiansheng Xu, and Yuhao Si. TM4SF4 Is a Diagnostic Biomarker Accelerating Progression of Papillary Thyroid Cancer via AKT Pathway. Taylor & Francis Group.
MLA (9th ed.) CitationLin, Lizhi, et al. TM4SF4 Is a Diagnostic Biomarker Accelerating Progression of Papillary Thyroid Cancer via AKT Pathway. Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.
       
       